My watch list
my.chemeurope.com  
Login  

Biotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation and purification. The customers include pharmaceutical and biotech companies, companies within the food industry and leading academic institutes. The company is headquartered in Uppsala and has offices in the US, UK, China and Japan. Biotage has approx. 290 employees and had sales of 610 MSEK in 2015. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange.

The group aims to accelerate the drug discovery and development process, and to increase knowledge by providing complete solutions for Medicinal and Analytical Chemistry and Process Development. The company aims to be market leading in each of its niche areas.

The company has a strong customer base of industry and academic partners, which include the world’s top 20 pharmaceutical companies and prestigious academic institutes such as the US National Institutes of Health, the US Centers for Disease Control and Prevention and the Karolinska Institute in Sweden.

Headquartered in Uppsala, Sweden, Biotage AB also has facilities in Lund, Sweden; Charlotte, NC, USA; Cardiff, UK; Tokyo and Osaka, Japan; and Shanghai, China.

More about Biotage
  • News

    Biotage Awarded Patent for Flash Purification Method Development and Optimization

    Biotage announced it has recently been awarded U.S. patent 7686959: Control system and Method for Flash Separation. The patented technology converts thin-layer chromatography (TLC) compound retention data into a linear gradient and also provides the user with sample loading estimates for an ... more

    Biotage AB Increases Focus on Environmental Market Segments

    Biotage AB announced plans to increase its focus on growing business opportunities in the environmental analysis business. The strategy includes redeployed marketing and sales resources along with new product development for specific application areas. In late 2007 Biotage launched EVOLUTE ... more

    Biotage AB Signs Two Exclusive Agreements with Reaxa

    Under a first agreement between Reaxa and Biotage both companies will develop "MicroEnCat(tm)" an encapsulated palladium catalyst range optimized for use in Biotage's Microwave Synthesizers, including the development of prefilled microwave vials and flow-through devices. A second agreement ... more

  • Companies

    Biotage, LLC

    Biotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation and purification. The customers include pharmaceutical and biotech companies, companies within the food industry and leading academic institutes. The c ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE